Mechanisms of decreased susceptibility to β-defensins by Treponema denticola

Infection and Immunity

Volumn 75, Issue 5, 2007, Pages 2307-2315

  Brissette, Catherine A ^a   Lukehart, Sheila A ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BETA DEFENSIN; BETA DEFENSIN 2; BETA DEFENSIN 3; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; DENTILISIN; PROTEINASE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SENSITIVITY; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; TREPONEMA DENTICOLA;

ANTI-INFECTIVE AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BETA-DEFENSINS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CARRIER PROTEINS; DRUG RESISTANCE, BACTERIAL; HUMANS; TREPONEMA DENTICOLA; UNCOUPLING AGENTS;

EID: 34248356762     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01718-06     Document Type: Article

References (76)

1. Abramson, I. J., and R. M. Smibert. 1971. Bactericidal activity of antimicrobial agents for treponemes. Br. J. Vener. Dis. 47:413-418.
2. Aimetti, M., F. Romano, I. Torta, D. Cirillo, P. Caposio, and R. Romagnoli. 2004. Debridement and local application of tetracycline-loaded fibres in the management of persistent periodontitis: results after 12 months. J. Clin. Periodontol. 31:166-172.
3. Alderete, J. F., and J. B. Baseman. 1979. Surface-associated host proteins on virulent Treponema pallidum. Infect. Immun. 26:1048-1056.
4. Belas, R., J. Manos, and R. Suvanasuthi. 2004. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect. Immun. 72:5159-5167.
5. Bengoechea, J. A., and M. Skurnik. 2000. Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia. Mol. Microbiol. 37:67-80.
6. Blakemore, R. P., and E. Canale-Parola. 1976. Arginine catabolism by Treponema denticola. J. Bacteriol. 128:616-622.
7. Bonass, W. A., A. S. High, P. J. Owen, and D. A. Devine. 1999. Expression of beta-defensin genes by human salivary glands. Oral Microbiol. Immunol. 14:371-374.
8. Borenstein, L. A., M. E. Selsted, R. I. Lehrer, and J. N. Miller. 1991. Antimicrobial activity of rabbit leukocyte defensins against Treponema pallidum subsp. pallidum. Infect. Immun. 59:1359-1367.
9. Brissette, C. A., and S. A. Lukehart. 2002. Treponema denticola is resistant to human beta-defensins. Infect. Immun. 70:3982-3984.
10. Brissette, C. A., L. G. Simonson, and S. A. Lukehart. 2004. Resistance to human beta-defensins is common among oral treponemes. Oral Microbiol. Immunol. 19:403-407.
11. Brown, M. H., I. T. Paulsen, and R. A. Skurray. 1999. The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol. Microbiol. 31:394-395.
12. Chan, E. C., R. Siboo, T. Keng, N. Psarra, R. Hurley, S. L. Cheng, and I. Iugovaz. 1993. Treponema denticola (ex Brumpt 1925) sp. nov., nom. rev., and identification of new spirochete isolates from periodontal pockets. Int. J. Syst. Bacteriol. 43:196-203.
13. +-coupled multidrug efflux pumps from Vibrio parahaemolyticus. J. Bacteriol. 184:572-576.
14. Collins, L. V., S. A. Kristian, C. Weidenmaier, M. Faigle, K. P. Van Kessel, J. A. Van Strijp, F. Gotz, B. Neumeister, and A. Peschel. 2002. Staphylococ cus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J. Infect. Dis. 186:214-219.
15. Cowan, M. M., F. H. Mikx, and H. J. Busscher. 1994. Electrophoretic mobility and hemagglutination of Treponema denticola ATCC 33520. Colloids Surf. B Biointerfac. 2:407-410.
16. Cox, D. L., Y. Sun, H. Liu, R. I. Lehrer, and W. M. Shafer. 2003. Susceptibility of Treponema pallidum to host-derived antimicrobial peptides. Peptides 24:1741-1746.
17. Dale, B. A., J. R. Kimball, S. Krisanaprakornkit, F. Roberts, M. Robinovitch, R. O'Neal, E. V. Valore, T. Ganz, G. M. Anderson, and A. Weinberg. 2001. Localized antimicrobial peptide expression in human gingiva. J. Periodontal Res. 36:285-294.
18. Dale, B. A., and S. Krisanaprakornkit. 2001. Defensin antimicrobial peptides in the oral cavity. J. Oral Pathol. Med. 30:321-327.
19. Darveau, R. P., A. Tanner, and R. C. Page. 2000. The microbial challenge in periodontitis. Periodontology 14:12-32.
20. Deng, Q. D., Y. Han, X. Xia, and H. K. Kuramitsu. 2001. Effects of the oral spirochete Treponema denticola on interleukin-8 expression from epithelial cells. Oral Microbiol. Immunol. 16:185-187.
21. Dorschner, R. A., B. Lopez-Garcia, A. Peschel, D. Kraus, K. Morikawa, V. Nizet, and R. L. Gallo. 2006. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J. 20:35-42.
22. Dunsche, A., Y. Acil, H. Dommisch, R. Siebert, J. M. Schroder, and S. Jepsen. 2002. The novel human beta-defensin-3 is widely expressed in oral tissues. Eur. J. Oral Sci. 110:121-124.
23. Dunsche, A., Y. Acil, R. Siebert, J. Harder, J. M. Schroder, and S. Jepsen. 2001. Expression profile of human defensins and antimicrobial proteins in oral tissues. J. Oral Pathol. Med. 30:154-158.
24. Ehmke, B., T. Beikler, B. Riep, T. Flemmig, U. Gobel, and A. Moter. 2004. Intraoral dissemination of treponemes after periodontal therapy. Clin. Oral Investig. 8:219-225.
25. Fenno, J. C., M. Tamura, P. M. Hannam, G. W. Wong, R. A. Chan, and B. C. McBride. 2000. Identification of a Treponema denticola OppA homologue that binds host proteins present in the subgingival environment. Infect. Immun. 68:1884-1892.
26. Genco, C. A., W. L. Maloy, U. P. Kari, and M. Motley. 2003. Antimicrobial activity of magainin analogues against anaerobic oral pathogens. Int. J. Antimicrob. Agents 21:75-78.
27. Gutsmann, T., S. O. Hagge, A. David, S. Roes, A. Bohling, M. U. Hammer, and U. Seydel. 2005. Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides. J. Endotoxin Res. 11: 167-173.
28. Harder, J., U. Meyer-Hoffert, L. M. Teran, L. Schwichtenberg, J. Bartels, S. Maune, and J. M. Schroder. 2000. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am. J. Respir. Cell Mol. Biol. 22:714-721.
29. Hoover, D. M., K. R. Rajashankar, R. Blumenthal, A. Puri, J. J. Oppenheim, O. Chertov, and J. Lubkowski. 2000. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J. Biol. Chem. 275:32911-32918.
30. Hoover, D. M., Z. Wu, K. Tucker, W. Lu, and J. Lubkowski. 2003. Antimicrobial characterization of human beta-defensin-3 derivatives. Antimicrob. Agents Chemother. 47:2804-2809.
31. Ishihara, K., H. K. Kuramitsu, T. Miura, and K. Okuda. 1998. Dentilisin activity affects the organization of the outer sheath of Treponema denticola. J. Bacteriol. 180:3837-3844.
32. Ishihara, K., T. Miura, H. K. Kuramitsu, and K. Okuda. 1996. Characterization of the Treponema denticola prtP gene encoding a prolyl-phenylalanine-specific protease (dentilisin). Infect. Immun. 64:5178-5186.
33. Jin, Y., J. Hammer, M. Pate, Y. Zhang, F. Zhu, E. Zmuda, and J. Blazyk. 2005. Antimicrobial activities and structures of two linear cationic peptide families with various amphipathic beta-sheet and alpha-helical potentials. Antimicrob. Agents Chemother. 49:4957-4964.
34. Joly, S., C. Maze, P. B. McCray, Jr., and J. M. Guthmiller. 2004. Human beta-defensins-2 and -3 demonstrate strain-selective activity against oral microorganisms. J. Clin. Microbiol. 42:1024-1029.
35. Jonas, B. M., B. E. Murray, and G. M. Weinstock. 2001. Characterization of emeA, a NorA homolog and multidrug resistance efflux pump, in Enterococcus faecalis. Antimicrob. Agents Chemother. 45:3574-3579.
36. Krisanaprakornkit, S., J. R. Kimball, A. Weinberg, R. P. Darveau, B. W. Bainbridge, and B. A. Dale. 2000. Inducible expression of human beta-defensin-2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. 68:2907-2915.
37. Loesche, W. J., J. Giordano, and P. P. Hujoel. 1990. The utility of the BANA test for monitoring anaerobic infections due to spirochetes (Treponema denticola) in periodontal disease. J. Dent. Res. 69:1696-1702.
38. Loesche, W. J., and N. S. Grossman. 2001. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin. Microbiol. Rev. 14:727-752.
39. Maisetta, G., G. Batoni, S. Esin, F. Luperini, M. Pardini, D. Bottai, W. Florio, M. R. Giuca, M. Gabriele, and M. Campa. 2003. Activity of human beta-defensin-3 alone or combined with other antimicrobial agents against oral bacteria. Antimicrob. Agents Chemother. 47:3349-3351.
40. Mathews, M., H. P. Jia, J. M. Guthmiller, G. Losh, S. Graham, G. K. Johnson, B. F. Tack, and P. B. McCray, Jr. 1999. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect. Immun. 67:2740-2745.
41. Mineshiba, F., S. Takashiba, J. Mineshiba, K. Matsuura, S. Kokeguchi, and Y. Murayama. 2003. Antibacterial activity of synthetic human beta-defensin-2 against periodontal bacteria. J. Int. Acad. Periodontol. 5:35-40.
42. Miyamae, S., H. Nikaido, Y. Tanaka, and F. Yoshimura. 1998. Active efflux of norfloxacin by Bacteroides fragilis. Antimicrob. Agents Chemother. 42: 2119-2121.
43. Miyasaki, K. T., A. L. Bodeau, M. E. Selsted, T. Ganz, and R. I. Lehrer. 1990. Killing of oral, Gram-negative, facultative bacteria by the rabbit defensin, NP-1. Oral Microbiol. Immunol. 5:315-319.
44. Miyasaki, K. T., R. Iofel, A. Oren, T. Huynh, and R. I. Lehrer. 1998. Killing of Fusobacterium nucleatum, Porphyromonas gingivalis and Prevotella inter media by protegrins. J. Periodontal Res. 33:91-98.
45. Miyasaki, K. T., and R. I. Lehrer. 1998. Beta-sheet antibiotic peptides as potential dental therapeutics. Int. J. Antimicrob. Agents 9:269-280.
46. Mousques, T., M. A. Listgarten, and R. W. Phillips. 1980. Effect of scaling and root planing on the composition of the human subgingival microbial flora. J. Periodontal Res. 15:144-151.
47. Nishimura, E., A. Eto, M. Kato, S. Hashizume, S. Imai, T. Nisizawa, and N. Hanada. 2004. Oral streptococci exhibit diverse susceptibility to human beta-defensin-2: antimicrobial effects of hBD-2 on oral streptococci. Curr. Microbiol. 48:85-87.
48. Ouhara, K., H. Komatsuzawa, S. Yamada, H. Shiba, T. Fujiwara, M. Ohara, K. Sayama, K. Hashimoto, H. Kurihara, and M. Sugai. 2005. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, beta-defensins and LL37, produced by human epithelial cells. J. Antimicrob. Chemother. 55:888-896.
49. Pages, J. M., M. Masi, and J. Barbe. 2005. Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol. Med. 11:382-389.
50. Peric, M., B. Bozdogan, M. R. Jacobs, and P. C. Appelbaum. 2003. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob Agents Chemother. 47: 1017-1022.
51. Peschel, A., R. W. Jack, M. Otto, L. V. Collins, P. Staubitz, G. Nicholson, H. Kalbacher, W. F. Nieuwenhuizen, G. Jung, A. Tarkowski, K. P. M. van Kessel, and J. A. G. van Strijp. 2001. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J. Exp. Med. 193:1067-1076.
52. Peschel, A., M. Otto, R. W. Jack, H. Kalbacher, G. Jung, and F. Gotz. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274: 8405-8410.
53. Poole, K. 2000. Efflux-mediated resistance to fluoroquinolones in Gram-positive bacteria and the mycobacteria. Antimicrob. Agents Chemother. 44:2595-2599.
54. Que, X. C., and H. K. Kuramitsu. 1990. Isolation and characterization of the Treponema denticola prtA gene coding for chymotrypsinlike protease activity and detection of a closely linked gene encoding PZ-PLGPA-hydrolyzing activity. Infect. Immun. 58:4099-4105.
55. Ricci, V., and L. J. Piddock. 2000. Accumulation of norfloxacin by Bacteroides fragilis. Antimicrob. Agents Chemother. 44:2361-2366.
56. Rouquette-Loughlin, C., S. A. Dunham, M. Kuhn, J. T. Balthazar, and W. M. Shafer. 2003. The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds. J. Bacteriol. 185: 1101-1106.
57. Sahasrabudhe, K. S., J. R. Kimball, T. H. Morton, A. Weinberg, and B. A. Dale. 2000. Expression of the antimicrobial peptide, human beta-defensin-1, in duct cells of minor salivary glands and detection in saliva. J. Dent. Res. 79:1669-1674.
58. Sahl, H. G., U. Pag, S. Bonness, S. Wagner, N. Antcheva, and A. Tossi. 2005. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol. 77:466-475.
59. Sakamoto, K., A. Margelles, H. W. van Veen, and W. N. Konings. 2001. Hop resistance in the beer spoilage bacterium Lactobacillus brevis is mediated by the ATP-binding cassette multidrug transporter HorA. J. Bacteriol. 183: 5371-5375.
60. Sakamoto, M., Y. Huang, M. Ohnishi, M. Umeda, I. Ishikawa, and Y. Benno. 2004. Changes in oral microbial profiles after periodontal treatment as determined by molecular analysis of 16S rRNA genes. J. Med. Microbiol. 53:563-571.
61. Sambri, V., A. Marangoni, L. Giacani, R. Gennaro, R. Murgia, R. Cevenini, and M. Cinco. 2002. Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. J. Antimicrob. Chemother. 50:895-902.
62. Satcher, D. S. 2000. Oral health in America: a report of the Surgeon General. U.S. Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health, Rockville, MD.
63. Schibli, D. J., H. N. Hunter, V. Aseyev, T. D. Starner, J. M. Wiencek, P. B. McCray, Jr., B. F. Tack, and H. J. Vogel. 2002. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of hBD-3 against Staphylococcus aureus. J. Biol. Chem. 277: 8279-8289.
64. Schultz, C. P., V. Wolf, R. Lange, E. Mertens, J. Wecke, D. Naumann, and U. Zahringer. 1998. Evidence for a new type of outer membrane lipid in oral spirochete Treponema denticola. Functioning permeation barrier without lipopolysaccharides. J. Biol. Chem. 273:15661-15666.
65. Scocchi, M., D. Romeo, and M. Cinco. 1993. Antimicrobial activity of two bactenecins against spirochetes. Infect. Immun. 61:3081-3083.
66. Seshadri, R., G. S. A. Myers, H. Tettelin, J. A. Eisen, J. F. Heidelberg, R. J. Dodson, T. M. Davidsen, R. T. DeBoy, D. E. Fouts, D. H. Haft, J. Selengut, Q. Ren, L. M. Brinkac, R. Madupu, J. Kolonay, S. A. Durkin, S. C. Daugherty, J. Shetty, A. Shvartsbeyn, E. Gebregeorgis, K. Geer, G. Tsegaye, J. Malek, B. Ayodeji, S. Shatsman, M. P. McLeod, D. Smajs, J. K. Howell, S. Pal, A. Amin, P. Vashisth, T. Z. McNeill, Q. Xiang, E. Sodergren, E. Baca, G. M. Weinstock, S. J. Norris, C. M. Fraser, and I. T. Paulsen. 2004. Comparison of the genome of the oral pathogen Trepo nema denticola with other spirochete genomes. Proc. Natl. Acad. Sci. USA 101:5646-5651.
67. Shafer, W. M., X. Qu, A. J. Waring, and R. I. Lehrer. 1998. Modulation of Neisseria gononhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. USA 95:1829-1833.
68. Sieprawska-Lupa, M., P. Mydel, K. Krawczyk, K. Wojcik, M. Puklo, B. Lupa, P. Suder, J. Silberring, M. Reed, J. Pohl, W. Shafer, F. McAleese, T. Foster, J. Travis, and J. Potempa. 2004. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48:4673-4679.
69. Simonson, L. G., P. J. Robinson, R. J. Pranger, M. E. Cohen, and H. E. Morton. 1992. Treponema denticola and Porphyromonas gingivalis as prognostic markers following periodontal treatment. J. Periodontol. 63:270-273.
70. Socransky, S. S., A. D. Haffajee, M. A. Cugini, C. Smith, and R. L. Kent, Jr. 1998. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25: 134-144.
71. Starner, T. D., W. E. Swords, M. A. Apicella, and P. B. McCray, Jr. 2002. Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation. Infect. Immun. 70: 5287-5289.
72. Tzeng, Y. L., K. D. Ambrose, S. Zughaier, X. Zhou, Y. K. Miller, W. M. Shafer, and D. S. Stephens. 2005. Cationic antimicrobial peptide resistance in Neisseria meningitidis. J. Bacteriol. 187:5387-5396.
73. Weinberg, A., S. Krisanaprakornkit, and B. A. Dale. 1998. Epithelial antimicrobial peptides: review and significance for oral applications. Crit. Rev. Oral Biol. Med. 9:399-414.
74. Wu, Q., L. Xu, X. Wang, S. Li, and B. Wang. 1992. Investigation of microbicidal activity of neutrophil defensins against leptospires. J. West China Univ. Med. Sci. 23:126-129. [Chinese.]
75. Wyss, C. 1992. Growth of Porphyromonas gingivalis, Treponema denticola, T. pectinovorum, T. socranskii, and T. vincentii in a chemically defined medium. J. Clin. Microbiol. 30:2225-2229.
76. Zhang, L., A. Rozek, and R. E. W. Hancock. 2001. Interaction of cationic antimicrobial peptides with model membranes. J. Biol. Chem. 276:35714-35722.